Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization

Age-related macular degeneration (AMD) is the primary cause of blindness in advanced countries. Repeated intravitreal delivery of anti-vascular endothelial growth factor (VEGF) agents has represented an important advancement for the therapy of wet AMD with significative results in terms of blindness...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarallo, Valeria, Iaccarino, Emanuela, Cicatiello, Valeria, Sanna, Riccardo, Ruvo, Menotti, De Falco, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014271/
https://www.ncbi.nlm.nih.gov/pubmed/31936463
http://dx.doi.org/10.3390/ijms21020410

Ejemplares similares

Ejemplares similares